Anew Medical, Inc. is a development‐stage medical device company focused on advancing minimally invasive circulatory support and thrombosis prevention technologies. The company’s lead product candidate, Aortix™, is a percutaneously delivered microaxial blood pump designed to provide up to 4 L/min of antegrade flow in the descending aorta. By eliminating the need for an external console and reducing vascular access size, Aortix™ aims to simplify high-risk percutaneous coronary intervention (PCI) and lower the incidence of hemodynamic complications during complex cardiovascular procedures.
In parallel with its circulatory support platform, Anew Medical is developing proprietary catheter coatings and antithrombotic surface treatments intended to minimize clot formation on indwelling vascular devices. These technologies target a broad range of applications, including hemodialysis catheters, central venous access ports and extracorporeal life support circuits. By integrating anti–thrombogenic materials into standard catheter designs, the company seeks to reduce the frequency of device‐related occlusions, infections and the need for repeated interventions.
Since its founding in 2005, Anew Medical has conducted preclinical studies and early feasibility trials to validate the safety and performance of its product candidates. The company is headquartered in Irvine, California, with R&D operations in Boston and a regulatory affairs team based in Zurich. Anew Medical is pursuing both U.S. Food and Drug Administration (FDA) investigational device exemptions and CE Mark approvals to enable initial clinical use in North America and Europe.
Leadership at Anew Medical brings together experience in cardiovascular device development and commercialization. Under the guidance of Chief Executive Officer Simon Hitchcock, the executive team has advanced Aortix™ through key proof‐of‐concept studies while securing strategic partnerships with leading interventional cardiology centers. Supported by a board of directors with deep expertise in medical technology and venture financing, Anew Medical is positioning its platform to address unmet needs in circulatory support and vascular access management worldwide.
AI Generated. May Contain Errors.
Free LEAS Stock Alerts